BNC

Biotechnology, Next challenge CREATING A BETTER LIFE

HOME

BNC KOREA

Global BNC

BNC KOREA to grow in global markets

BNC KOREA has secured the sustainable growth engine by developing global markets in Europe, China, Brazil, India and Indonesia.

· Export of CE certificated dermal filler to Europe through Servia, Bosnia and Poland
· Export of products to 45 countries
· Signing of contract to export dermal filler amounting to at least US 3 million annually (US-based company, signing of OEM export)
· Signing of contract to supply 1 million units annually to a Chinese company (CFDA certificated expected in 2021)
· Expansion of overseas market through approval of exports of new drug substances
· Registering medical appliances (dermal filler and anti-adhesion barrier gel) with local partners to enter the emerging markets in South America, including Brazil, the Middle East, India and Indonesia
· Completed approval of export botulinum toxin ‘BIENOX’ (Domestic sales license expected in ’22) From filler and derma cosmetics to botulinum toxin, forming the ‘medical beauty’ lineup